These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

185 related items for PubMed ID: 2917701

  • 1. Gemfibrozil alone and in combination with lovastatin for treatment of hypertriglyceridemia in NIDDM.
    Garg A, Grundy SM.
    Diabetes; 1989 Mar; 38(3):364-72. PubMed ID: 2917701
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Effect of gemfibrozil and lovastatin on postprandial lipoprotein clearance in the hypoalphalipoproteinemia and hypertriglyceridemia syndrome.
    Simo IE, Yakichuk JA, Ooi TC.
    Atherosclerosis; 1993 Apr; 100(1):55-64. PubMed ID: 8318063
    [Abstract] [Full Text] [Related]

  • 5. A comparison of lovastatin, an HMG-CoA reductase inhibitor, with gemfibrozil, a fibrinic acid derivative, in the treatment of patients with diabetic dyslipidemia.
    Bell DS.
    Clin Ther; 1995 Apr; 17(5):901-10. PubMed ID: 8595642
    [Abstract] [Full Text] [Related]

  • 6. Comparison of the effects of lovastatin and gemfibrozil on lipids and glucose control in non-insulin-dependent diabetes mellitus.
    Goldberg R, La Belle P, Zupkis R, Ronca P.
    Am J Cardiol; 1990 Sep 18; 66(8):16B-21B. PubMed ID: 2206032
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Combination drug therapy for familial combined hyperlipidemia.
    East C, Bilheimer DW, Grundy SM.
    Ann Intern Med; 1988 Jul 01; 109(1):25-32. PubMed ID: 3288029
    [Abstract] [Full Text] [Related]

  • 10. A crossover comparison of the efficacy and safety of lovastatin and gemfibrozil in the treatment of hyperlipidemic organ transplant recipients.
    Hanes DS, Nicholson PG, Raval DD, Hooper FL, Behrens MT, Weir MR.
    Am J Ther; 1997 Jul 01; 4(2-3):85-91. PubMed ID: 10423597
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. The influence of simvastatin alone or in combination with gemfibrozil on plasma lipids and lipoproteins in patients with type III hyperlipoproteinemia.
    Feussner G, Eichinger M, Ziegler R.
    Clin Investig; 1992 Nov 01; 70(11):1027-35. PubMed ID: 1472833
    [Abstract] [Full Text] [Related]

  • 15. Effects of gemfibrozil on very-low-density lipoprotein composition and low-density lipoprotein size in patients with hypertriglyceridemia or combined hyperlipidemia.
    Yang CY, Gu ZW, Xie YH, Valentinova NV, Yang M, Yeshurun D, Quion JA, Gotto AM.
    Atherosclerosis; 1996 Sep 27; 126(1):105-16. PubMed ID: 8879439
    [Abstract] [Full Text] [Related]

  • 16. Influence of lovastatin plus gemfibrozil on plasma lipids and lipoproteins in patients with heterozygous familial hypercholesterolemia.
    Illingworth DR, Bacon S.
    Circulation; 1989 Mar 27; 79(3):590-6. PubMed ID: 2645064
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. The effect of gemfibrozil on lipid profile and glucose metabolism in hypertriglyceridaemic well-controlled non-insulin-dependent diabetic patients. For the Gemfibrozil Study Group.
    Avogaro A, Piliego T, Catapano A, Miola M, Tiengo A.
    Acta Diabetol; 1999 Jun 27; 36(1-2):27-33. PubMed ID: 10436249
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.